One of the key requirements of the new pharmacovigilance legislation (Regulation 726/2004) in the EU is simplified reporting of individual case safety reports (ICSRs) by a Marketing Authorization Holder (MAH) to the new EudraVigilance (EV) system

Share on LinkedIn

Related Posts

Webinar: Operationalizing AI Across the PV Lifecycle Towards Real ROI

Learn how leading life sciences organizations are scaling AI across PV operations to deliver tangible results.

Experience LifeSphere in Action

Unlock the full potential of your organization with LifeSphere.